Related Experiment Video
Updated: Jan 22, 2026

Characterizing Herbivore Resistance Mechanisms: Spittlebugs on Brachiaria spp. as an Example
Published on: June 19, 2011
Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib
Niamh Coleman1, Andrew Wotherspoon2, Nadia Yousaf1
1Lung Unit, The Royal Marsden Hospital, 203 Fulham Rd, Chelsea, London, SW3 6JJ, United Kingdom.
Objectives:
Small cell transformation is a well-recognized mechanism of resistance to EGFR-TKI therapy in EGFR-mutant NSCLC, yet it remains a poorly-described phenomenon in ALK-rearranged NSCLC.
Material And Methods:
Chart and literature review.
Results:
We report a case of a patient with ALK-rearranged lung cancer progressing on three-lines of ALK-targeted therapies, with development of acquired resistance to lorlatinib, with both transformation to a neuroendocrine carcinoma, and acquisition of ALK 1196 M.
Conclusions:
Given the inevitable development of resistance in ALK + NSCLC, if feasible, re-biopsy on progression should be standard over liquid biopsy. Neuroendocrine carcinoma transformation remains an important mechanism of acquired resistance to lorlatinib.
Insights
Small cell transformation is a resistance mechanism in ALK-positive lung cancer. Re-biopsy is recommended to identify neuroendocrine carcinoma transformation and guide treatment for ALK-rearranged NSCLC.
Area of Science:
- Oncology
- Translational Research
- Genomics
Background:
- Anaplastic Lymphoma Kinase (ALK)-rearranged Non-Small Cell Lung Cancer (NSCLC) often develops resistance to targeted therapies.
- Small cell transformation is a known resistance mechanism in EGFR-mutant NSCLC but is less understood in ALK-rearranged NSCLC.
Observation:
- A case of ALK-rearranged NSCLC is presented, where the patient progressed despite three lines of ALK-targeted therapies.
- Acquired resistance to lorlatinib was observed, characterized by transformation to neuroendocrine carcinoma and acquisition of the ALK G1196A mutation.
Findings:
- Neuroendocrine carcinoma transformation is a significant mechanism of acquired resistance to lorlatinib in ALK-rearranged NSCLC.
- The study highlights a specific case demonstrating this transformation and a concurrent ALK mutation.
Implications:
- Re-biopsy upon progression in ALK-positive NSCLC is crucial for accurate diagnosis and treatment selection, potentially offering more insights than liquid biopsies.
- Understanding neuroendocrine transformation is vital for developing future therapeutic strategies against resistant ALK-rearranged NSCLC.
More Related Videos
12:04Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Resistivity
Resistance
Transformation
Transformers
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...